Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Kura Oncology Inc..
Kura Oncology Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Kura Oncology Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Kura Oncology Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Kura Oncology Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Kura Oncology Inc. and all latest updates of the company are provided.
The 2025 version of Kura Oncology Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Kura Oncology Inc.- Key Facts
2.2 Kura Oncology Inc.- Geographic Locations
2.3 Kura Oncology Inc.- Subsidiaries and Affiliates
2.4 Kura Oncology Inc.- Business Divisions
2.5 Kura Oncology Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Kura Oncology Inc. Strategic Analysis Review
3.1 Kura Oncology Inc.- Key Strategies
3.2 Kura Oncology Inc.- Company Outlook Statement
3.3 Kura Oncology Inc.- SWOT Analysis
3.3.1 Kura Oncology Inc.- Key Strengths
3.3.2 Kura Oncology Inc.- Key Weaknesses
3.3.3 Kura Oncology Inc.- Potential Opportunities
3.3.4 Kura Oncology Inc.- Potential Threats
3.4 Kura Oncology Inc.- Key Competitors
4. Business Description of the Company
4.1 Kura Oncology Inc.- Business Overview
4.2 Kura Oncology Inc.- Operations by Segment
5 Products and Services Details
5.1 Kura Oncology Inc.- Key Products
5.2 Kura Oncology Inc.- Key Service Areas
5.3 Kura Oncology Inc.- Key Brands
6 Company Developments
6.1 Kura Oncology Inc.- Company History
6.2 Kura Oncology Inc.- Latest Developments
7 Financial Analysis
7.1 Kura Oncology Inc.- Income Statements
7.2 Kura Oncology Inc.- Balance Sheet
7.3 Kura Oncology Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Kura Oncology Inc.- Direct Competitors
8.2 Kura Oncology Inc.- Competitor Financial Ratios comparison
8.3 Kura Oncology Inc.- Competitor Stock Charts Comparison
8.4 Kura Oncology Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!